Bafna Pharmaceuticals Limited (NSE:BAFNAPH)

Bafna Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 22, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	2,775	1,769	1,853	1,940	2,996	3,252
Market Cap Growth	43.11%	-4.53%	-4.45%	-35.25%	-7.86%	10234.58%
Enterprise Value	3,097	1,945	1,941	2,104	3,042	3,275
Last Close Price	117.32	74.80	78.35	82.00	126.65	137.45
PE Ratio	31.64	42.61	25.23	17.11	57.44	55.81
PS Ratio	1.95	1.21	1.22	1.68	3.52	4.57
PB Ratio	3.04	2.09	2.29	2.64	4.84	5.73
P/TBV Ratio	3.04	2.09	2.34	2.70	4.84	5.73
P/FCF Ratio	-	640.66	-	-	136.99	-
P/OCF Ratio	17.97	7.99	19.54	39.17	30.80	-
EV/Sales Ratio	2.18	1.33	1.27	1.82	3.57	4.60
EV/EBITDA Ratio	19.31	16.63	16.94	12.30	25.07	30.83
EV/EBIT Ratio	27.35	28.59	30.03	17.88	45.81	53.29
EV/FCF Ratio	-22.85	704.05	-	-	139.09	-
Debt / Equity Ratio	0.36	0.33	0.30	0.31	0.18	0.28
Debt / EBITDA Ratio	2.02	2.41	2.13	1.34	0.91	1.49
Debt / FCF Ratio	-	102.10	-	-	5.06	-
Asset Turnover	0.97	0.97	1.10	1.05	0.96	0.90
Inventory Turnover	3.29	3.58	4.14	3.62	2.89	3.39
Quick Ratio	0.69	0.84	0.87	1.05	0.68	0.92
Current Ratio	1.67	1.66	1.73	1.88	2.31	2.04
Return on Equity (ROE)	10.08%	5.01%	9.53%	16.74%	8.79%	10.82%
Return on Assets (ROA)	4.80%	2.83%	2.91%	6.70%	4.70%	4.88%
Return on Invested Capital (ROIC)	9.72%	6.37%	6.72%	14.24%	9.25%	10.57%
Return on Capital Employed (ROCE)	10.00%	6.70%	6.90%	14.20%	9.70%	9.90%
Earnings Yield	3.16%	2.35%	3.96%	5.85%	1.74%	1.79%
FCF Yield	-4.88%	0.16%	-3.29%	-0.91%	0.73%	-6.06%
Buyback Yield / Dilution	-0.04%	-	-	-	0.13%	-901.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.